Cells | Free Full-Text | Cell-Type Targeted NF-kappaB Inhibition for the Treatment of Inflammatory Diseases
Biology of RANK, RANKL, and osteoprotegerin | Arthritis Research & Therapy | Full Text
NFκB (Nuclear Factor κ-Light-Chain Enhancer of Activated B Cells) Activity Regulates Cell-Type–Specific and Context-Specific Susceptibility to Calcification in the Aortic Valve | Arteriosclerosis, Thrombosis, and Vascular Biology
anti-RANk antibody | Rabbit anti-Human Receptor Activator Of Nuclear Factor Kappa B Polyclonal Antibody-NP_001257878.1
Frontiers | Nuclear Factor-kappaB in Autoimmunity: Man and Mouse
Rat RANk (Receptor Activator of Nuclear Factor Kappa B) CLIA Kit (RTES00090)
RANK - Wikipedia
Expression of the RANK/RANKL/OPG system in the human intervertebral disc: implication for the pathogenesis of intervertebral disc degeneration | BMC Musculoskeletal Disorders | Full Text
The regulatory action of osteoprotegerin (OPG) and receptor activator... | Download Scientific Diagram
Nuclear factor‐kappa β as a therapeutic target for Alzheimer's disease - Jha - 2019 - Journal of Neurochemistry - Wiley Online Library
Nuclear Factor κB Signaling in Atherogenesis | Arteriosclerosis, Thrombosis, and Vascular Biology
RANk active protein | Receptor Activator Of Nuclear Factor Kappa B (RANk) Active Protein-NP_001257878.1
Frontiers | Roles of osteoprotegerin in endocrine and metabolic disorders through receptor activator of nuclear factor kappa-B ligand/receptor activator of nuclear factor kappa-B signaling